Prevalence and outcomes of antibiotic resistant infections at MSF projects

MSF Scientific Days in Latin America 2024 focused on two thematic areas:

Climate Emergency in the Americas: What Are We Seeing as a Medical Humanitarian Organization and How Are We Responding?

• MSF has long responded to health crises aggravated by the climate emergency —such as disease outbreaks, food insecurity, and displacement—and these events are intensifying in severity and frequency. This session presented examples of how MSF is adapting to address climate-related emergencies in the region, and explored strategies for future humanitarian action.

Mental Health and Psychosocial Support Interventions in Violence, Migration, and Indigenous Health Projects

• This session explored the complexities of providing mental health and psychosocial support (MHPSS) in some of the region’s most challenging settings. It focused on interventions in areas affected by violence, the mental health impact on migrants, and the unique needs of indigenous populations. The discussion highlighted innovative strategies, culturally sensitive approaches, and the importance of integrating MHPSS into healthcare projects in these complex settings.

Tuberculosis (TB) is the world's deadliest infectious disease, and the leading killer of people with HIV. TB is curable, but it can be difficult to diagnose and tough to treat, especially for increasingly prevalent drug-resistant TB. In 2023, 22,700 people started TB treatment in MSF programs. Understanding the costs and cost-effectiveness associated with TB treatment and innovations, ranging from TB diagnostics and medications to TB care models, can help to plan resource needs and allocate resources effectively. Analyzing financing mechanisms can support developing sustainable funding models for TB control.

This collection spotlights articles by MSF and collaborators to analyze and document the costs of care, particularly diagnostics and medications.